4-Bromo-N-tert-butyl-N-[(4-methoxyphenyl)methyl]benzene-1-sulfonamide

Catalog No. :
ACPRQL785
CAS No. :
1881330-94-4
Molecular Formula :
C18H22BrNO3S
Molecular Weight :
412.35

IUPAC Name:4-bromo-N-(tert-butyl)-N-(4-methoxybenzyl)benzenesulfonamide

4-Bromo-N-tert-butyl-N-[(4-methoxyphenyl)methyl]benzene-1-sulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$384.00Login to see priceInquiryInquiry
5g95%$1153.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-N-tert-butyl-N-[(4-methoxyphenyl)methyl]benzene-1-sulfonamide
IUPAC Name4-bromo-N-(tert-butyl)-N-(4-methoxybenzyl)benzenesulfonamide
MDL No.MFCD29044000
Molecular FormulaC18H22BrNO3S
Molecular Weight412.35
SMILESCOC1=CC=C(C=C1)CN(S(=O)(C2=CC=C(C=C2)Br)=O)C(C)(C)C
InChI KeyYDRACNSAQHMPTE-UHFFFAOYSA-N
SynonymBenzenesulfonamide, 4-bromo-N-(1,1-dimethylethyl)-N-[(4-methoxyphenyl)methyl]-;4-bromo-N-tert-butyl-N-[(4-methoxyphenyl)methyl]benzene-1-sulfonamide
CAS No.1881330-94-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPRQL785 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPRQL785 route product structure diagram
    ACPRQL7851881330-94-4
Inquiry

2. ACPRQL785 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXPYN430 route compound structure diagram
    ACXPYN43093281-65-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPRQL785 route product structure diagram
    ACPRQL7851881330-94-4
Inquiry

Comments (0)